Stephen Barclay
@stephentbarclay.bsky.social
Consultant Gastroenterologist, Glasgow Royal Infirmary - interested in all things liver. Liversky, Livertwitter
Reposted by Stephen Barclay
First first author article for Eemeli Puhakka published!
We identified a profile of metabolites separating those with early stage progressive alcohol-related liver disease from non-progressive alcohol-related liver disease using metabolomics
doi.org/10.1111/liv....
#metabolomics #alcohol
We identified a profile of metabolites separating those with early stage progressive alcohol-related liver disease from non-progressive alcohol-related liver disease using metabolomics
doi.org/10.1111/liv....
#metabolomics #alcohol
Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol‐Related Liver Disease: A Cross‐Sectional Metabolomics Study
Background and Aims Alcohol-related liver disease (ALD) is a major cause of mortality and disability-adjusted life years. It is not fully understood why a small proportion of patients develop progre...
doi.org
May 14, 2025 at 7:10 PM
First first author article for Eemeli Puhakka published!
We identified a profile of metabolites separating those with early stage progressive alcohol-related liver disease from non-progressive alcohol-related liver disease using metabolomics
doi.org/10.1111/liv....
#metabolomics #alcohol
We identified a profile of metabolites separating those with early stage progressive alcohol-related liver disease from non-progressive alcohol-related liver disease using metabolomics
doi.org/10.1111/liv....
#metabolomics #alcohol
Emails this evening between colleagues in Scotland about HCC surveillance in HBV patients from Sub-Saharan Africa, many performing surveillance at a young age but questioning need (if no advanced fibrosis) in light of pubmed.ncbi.nlm.nih.gov/37898348/ what are others doing? #liversky #hepsky
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe - PubMed
Sub-Saharan African ethnicity has been associated with a higher risk of hepatocellular carcinoma among individuals with chronic hepatitis B. In this international multicenter cohort study of sub-Sahar...
pubmed.ncbi.nlm.nih.gov
December 2, 2024 at 9:19 PM
Emails this evening between colleagues in Scotland about HCC surveillance in HBV patients from Sub-Saharan Africa, many performing surveillance at a young age but questioning need (if no advanced fibrosis) in light of pubmed.ncbi.nlm.nih.gov/37898348/ what are others doing? #liversky #hepsky
Reposted by Stephen Barclay
New people added to the PSC Starter Pack
go.bsky.app/6hLJsJT
Help PSC researchers to connect. Who should be added?
go.bsky.app/6hLJsJT
Help PSC researchers to connect. Who should be added?
November 27, 2024 at 10:46 PM
New people added to the PSC Starter Pack
go.bsky.app/6hLJsJT
Help PSC researchers to connect. Who should be added?
go.bsky.app/6hLJsJT
Help PSC researchers to connect. Who should be added?
Reposted by Stephen Barclay
www.bbc.com/news/article...
Nice to see Debbie Shawcross (not on here yet!), @drgautammehta.bsky.social and others really highlighting this issue on various BBC platforms today!
#LiverSky
@adhanda.bsky.social
@aleksanderkrag.bsky.social
Nice to see Debbie Shawcross (not on here yet!), @drgautammehta.bsky.social and others really highlighting this issue on various BBC platforms today!
#LiverSky
@adhanda.bsky.social
@aleksanderkrag.bsky.social
‘At 31, I was told if I didn’t stop drinking, I could die’
BBC journalist Hazel Martin was told she had liver fibrosis and must go teetotal or she could die.
www.bbc.com
November 25, 2024 at 6:47 AM
www.bbc.com/news/article...
Nice to see Debbie Shawcross (not on here yet!), @drgautammehta.bsky.social and others really highlighting this issue on various BBC platforms today!
#LiverSky
@adhanda.bsky.social
@aleksanderkrag.bsky.social
Nice to see Debbie Shawcross (not on here yet!), @drgautammehta.bsky.social and others really highlighting this issue on various BBC platforms today!
#LiverSky
@adhanda.bsky.social
@aleksanderkrag.bsky.social
Reposted by Stephen Barclay
Very excited to be on @bbcnews-uk-rss.bsky.social Panorama tomorrow, talking about the hidden harms of binge drinking @stsucl.bsky.social #alcohol #livertwitter #PublicHealth
November 24, 2024 at 8:52 PM
Very excited to be on @bbcnews-uk-rss.bsky.social Panorama tomorrow, talking about the hidden harms of binge drinking @stsucl.bsky.social #alcohol #livertwitter #PublicHealth
Reposted by Stephen Barclay
Pleased to see the publication of our paper showing effective management of alcohol withdrawal syndrome in patients with coexistent alcohol-related liver disease using GMAWS.
Great contributions by our medical students: Stroma Harcombe, Lujine Ibrahim, Georgia Smith and Alex Doyle.
t.co/fEjeZChSVI
Great contributions by our medical students: Stroma Harcombe, Lujine Ibrahim, Georgia Smith and Alex Doyle.
t.co/fEjeZChSVI
November 20, 2024 at 2:10 PM
Pleased to see the publication of our paper showing effective management of alcohol withdrawal syndrome in patients with coexistent alcohol-related liver disease using GMAWS.
Great contributions by our medical students: Stroma Harcombe, Lujine Ibrahim, Georgia Smith and Alex Doyle.
t.co/fEjeZChSVI
Great contributions by our medical students: Stroma Harcombe, Lujine Ibrahim, Georgia Smith and Alex Doyle.
t.co/fEjeZChSVI
Reposted by Stephen Barclay
Share your best blue sky photo from your phone
November 18, 2024 at 12:36 AM
Share your best blue sky photo from your phone
Reposted by Stephen Barclay
Yes!
And low qHBsAg patients are not the majority in our clinics… many left behind
And low qHBsAg patients are not the majority in our clinics… many left behind
November 19, 2024 at 6:58 PM
Yes!
And low qHBsAg patients are not the majority in our clinics… many left behind
And low qHBsAg patients are not the majority in our clinics… many left behind
Reflecting on the raft of early phase HBV trials at #TLM24. Good to see new compounds with different MOAs moving forward- however so many of the inclusion criteria were for subjects with low qHBsAg who would have a good chance of S loss with just stopping their NA 🤷🏻♂️ #liversky
November 19, 2024 at 6:56 PM
Reposted by Stephen Barclay
Excellent study: the 40mg prednisolone for 28 days has been ripe for challenging for a long time now. Dose and duration established only by historical quirk rather than evidence. Need to assess targeted (I would argue NLR rather than severity based) tapered/short duration treatment.
#liversky
#liversky
November 19, 2024 at 11:09 AM
Excellent study: the 40mg prednisolone for 28 days has been ripe for challenging for a long time now. Dose and duration established only by historical quirk rather than evidence. Need to assess targeted (I would argue NLR rather than severity based) tapered/short duration treatment.
#liversky
#liversky
Reposted by Stephen Barclay
The best review on PSC that I have read
journals.lww.com/hepcomm/full...
🫡 @autoimmuneliver.bsky.social
#medsky #liversky
journals.lww.com/hepcomm/full...
🫡 @autoimmuneliver.bsky.social
#medsky #liversky
Management of primary sclerosing cholangitis: Current... : Hepatology Communications
and colorectal cancer. Medical therapies are lacking, and this, in part, reflects a poor grasp of disease biology. As a result, current management is largely supportive, with liver transplantation an ...
journals.lww.com
November 17, 2024 at 2:57 PM
The best review on PSC that I have read
journals.lww.com/hepcomm/full...
🫡 @autoimmuneliver.bsky.social
#medsky #liversky
journals.lww.com/hepcomm/full...
🫡 @autoimmuneliver.bsky.social
#medsky #liversky
Reposted by Stephen Barclay
Just updated
Keep it coming
Keep it coming
Sharing #gisky and #liversky
Will add to it by end of day
Let me know and I will update
go.bsky.app/8Pho2tp
Will add to it by end of day
Let me know and I will update
go.bsky.app/8Pho2tp
November 11, 2024 at 7:59 PM
Just updated
Keep it coming
Keep it coming
Reposted by Stephen Barclay
@ebtapper.bsky.social @pallettlab.bsky.social @boulterlab.bsky.social @livernotfighter.bsky.social
A #LiverSky feed that appears to function, go tell your pals!
bsky.app/profile/did:...
A #LiverSky feed that appears to function, go tell your pals!
bsky.app/profile/did:...
October 13, 2023 at 7:46 PM
@ebtapper.bsky.social @pallettlab.bsky.social @boulterlab.bsky.social @livernotfighter.bsky.social
A #LiverSky feed that appears to function, go tell your pals!
bsky.app/profile/did:...
A #LiverSky feed that appears to function, go tell your pals!
bsky.app/profile/did:...
Glad to be on #medsky - any refugees from #livertwitter made it across yet?
October 13, 2023 at 10:28 PM
Glad to be on #medsky - any refugees from #livertwitter made it across yet?